Subsequently, flow cytometry confirmed that deletion of SH3TC2 could arrest the cycle of HCT116 and SW480 cells at the G0/G1 phase (Figure 4(d)), indicating that SH3TC2 is required for maintaining cell-cycle progress in CRC. The gene discussed is SH3TC2; the disease is colorectal carcinoma.